$PMCB News Marijuana is a booming boomer busin
Post# of 144482
Posted On: 02/01/2016 3:46:48 PM
$PMCB News
Marijuana is a booming boomer business 4:00 a.m. July 15, 2014 - Robyn Griggs Lawrence
Trading Ahead of Upcoming Developments -- New Research on Trans-Pacific Aerospace Company, Pharmacyte Biotech, First Mining Finance, and Accretive Health 9:05 a.m. Today - ACCESSWIRE
PharmaCyte Executives Meet With Translational Drug Development to Advance Pancreatic Cancer Clinical Trial 9:25 a.m. Jan. 25, 2016 - GlobeNewswire
The Road Ahead -- Featured Research on SpectraScience, Pharmacyte Biotech, Silvercorp Metals and Aytu BioScience 9:12 a.m. Jan. 21, 2016 - ACCESSWIRE
PharmaCyte Biotech Introduces Cell-in-a-Box as a Novel Treatment for Pancreatic Cancer and Potential Cure for Type 1 Diabetes 9:26 a.m. Jan. 19, 2016 - GlobeNewswire
PharmaCyte Biotech Raises Additional $1 Million for Pancreatic Cancer Clinical Trial 9:25 a.m. Jan. 14, 2016 - GlobeNewswire
Perception, Opportunity in Volatility - Free Research on Ambient Water, Pharmacyte Biotech, Soligenix and Epsilon Energy 8:03 a.m. Jan. 14, 2016 - ACCESSWIRE
PharmaCyte Biotech to Attend J.P. Morgan Healthcare Conference 9:00 a.m. Jan. 7, 2016 - GlobeNewswire
PharmaCyte Biotech Outlines 2016 Milestones as Its Pancreatic Cancer Treatment Moves Into a Clinical Trial 8:45 a.m. Jan. 4, 2016 - GlobeNewswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of PharmaCyte Biotech, Inc. (OTCMKTS: PMCB) 1:01 p.m. Dec. 31, 2015 - PR Newswire - PRF
PharmaCyte Biotech End of Year Shareholder Update on Pancreatic Cancer and Diabetes Programs 9:01 a.m. Dec. 30, 2015 - GlobeNewswire
PharmaCyte Biotech Releases New Video Highlighting Diabetes Treatment Development Program 9:25 a.m. Dec. 15, 2015 - GlobeNewswire
PharmaCyte Biotech Provides Update on Malignant Ascites and New Colon Cancer Studies 9:25 a.m. Dec. 7, 2015 - GlobeNewswire
PharmaCyte Contractor Chamow & Associates to Visit Cell-in-a-Box(R) Encapsulation Facility in Bangkok, Thailand 9:26 a.m. Dec. 4, 2015 - GlobeNewswire
PharmaCyte Biotech Provides Link to Orphan Drug Designation for Its Pancreatic Cancer Treatment 9:25 a.m. Nov. 24, 2015 - GlobeNewswire
A Look Inside the Chart, Technical Insights - Research on LivePerson, Pharmacyte Biotech, Agenus, and Straight Path Communications 8:05 a.m. Nov. 24, 2015 - ACCESSWIRE
PharmaCyte Biotech Announces Appointment of International Diabetes Expert to Scientific Advisory Board 10:41 a.m. Nov. 19, 2015 - GlobeNewswire
PharmaCyte Biotech Appoints International Diabetes Expert to Its Scientific Advisory Board 9:25 a.m. Nov. 19, 2015 - GlobeNewswire
PharmaCyte Biotech Obtains Orphan Drug Designation in Europe for Its Pancreatic Cancer Treatment 9:23 a.m. Nov. 17, 2015 - GlobeNewswire
A Look Inside the Chart, Technical Insights - Research on Student Transportation, Medical Marijuana, NanoTech Entertainment and Pharmacyte Biotech 8:15 a.m. Nov. 16, 2015 - ACCESSWIRE
Broad Street Alerts - PharmaCyte Biotech Investor Update: Revolutionizing Potential Diabetes Treatment 8:21 a.m. Nov. 12, 2015 - PR Newswire - PRF
Marijuana is a booming boomer business 4:00 a.m. July 15, 2014 - Robyn Griggs Lawrence
Trading Ahead of Upcoming Developments -- New Research on Trans-Pacific Aerospace Company, Pharmacyte Biotech, First Mining Finance, and Accretive Health 9:05 a.m. Today - ACCESSWIRE
PharmaCyte Executives Meet With Translational Drug Development to Advance Pancreatic Cancer Clinical Trial 9:25 a.m. Jan. 25, 2016 - GlobeNewswire
The Road Ahead -- Featured Research on SpectraScience, Pharmacyte Biotech, Silvercorp Metals and Aytu BioScience 9:12 a.m. Jan. 21, 2016 - ACCESSWIRE
PharmaCyte Biotech Introduces Cell-in-a-Box as a Novel Treatment for Pancreatic Cancer and Potential Cure for Type 1 Diabetes 9:26 a.m. Jan. 19, 2016 - GlobeNewswire
PharmaCyte Biotech Raises Additional $1 Million for Pancreatic Cancer Clinical Trial 9:25 a.m. Jan. 14, 2016 - GlobeNewswire
Perception, Opportunity in Volatility - Free Research on Ambient Water, Pharmacyte Biotech, Soligenix and Epsilon Energy 8:03 a.m. Jan. 14, 2016 - ACCESSWIRE
PharmaCyte Biotech to Attend J.P. Morgan Healthcare Conference 9:00 a.m. Jan. 7, 2016 - GlobeNewswire
PharmaCyte Biotech Outlines 2016 Milestones as Its Pancreatic Cancer Treatment Moves Into a Clinical Trial 8:45 a.m. Jan. 4, 2016 - GlobeNewswire
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of PharmaCyte Biotech, Inc. (OTCMKTS: PMCB) 1:01 p.m. Dec. 31, 2015 - PR Newswire - PRF
PharmaCyte Biotech End of Year Shareholder Update on Pancreatic Cancer and Diabetes Programs 9:01 a.m. Dec. 30, 2015 - GlobeNewswire
PharmaCyte Biotech Releases New Video Highlighting Diabetes Treatment Development Program 9:25 a.m. Dec. 15, 2015 - GlobeNewswire
PharmaCyte Biotech Provides Update on Malignant Ascites and New Colon Cancer Studies 9:25 a.m. Dec. 7, 2015 - GlobeNewswire
PharmaCyte Contractor Chamow & Associates to Visit Cell-in-a-Box(R) Encapsulation Facility in Bangkok, Thailand 9:26 a.m. Dec. 4, 2015 - GlobeNewswire
PharmaCyte Biotech Provides Link to Orphan Drug Designation for Its Pancreatic Cancer Treatment 9:25 a.m. Nov. 24, 2015 - GlobeNewswire
A Look Inside the Chart, Technical Insights - Research on LivePerson, Pharmacyte Biotech, Agenus, and Straight Path Communications 8:05 a.m. Nov. 24, 2015 - ACCESSWIRE
PharmaCyte Biotech Announces Appointment of International Diabetes Expert to Scientific Advisory Board 10:41 a.m. Nov. 19, 2015 - GlobeNewswire
PharmaCyte Biotech Appoints International Diabetes Expert to Its Scientific Advisory Board 9:25 a.m. Nov. 19, 2015 - GlobeNewswire
PharmaCyte Biotech Obtains Orphan Drug Designation in Europe for Its Pancreatic Cancer Treatment 9:23 a.m. Nov. 17, 2015 - GlobeNewswire
A Look Inside the Chart, Technical Insights - Research on Student Transportation, Medical Marijuana, NanoTech Entertainment and Pharmacyte Biotech 8:15 a.m. Nov. 16, 2015 - ACCESSWIRE
Broad Street Alerts - PharmaCyte Biotech Investor Update: Revolutionizing Potential Diabetes Treatment 8:21 a.m. Nov. 12, 2015 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼